Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sotrastaurin-tacrolimus to mycophenolic acid-tacrolimus in de novo liver transplant patients, assessing efficacy, safety, tolerability, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Mycophenolic acid-tacrolimus (mycophenolic acid-tacrolimus)
• Sotrastaurin-tacrolimus (sotrastaurin-tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplantation | Phase 2 | Status: COMPLETED